Current best evidence indicates that tranexamic acid may reduce both the duration and volume of bleeding, with low risk of short-term thromboembolic complications, in patients with haemoptysis.
To study the effects of platelet-rich plasma (PRP) on the proliferation and osteogenetic activity of the marrow mesenchymal stem cells (MSCs) cultured in vitro to elucidate the cellular and molecular mechanism by which PRP accelerates bone repair.
